Octagam [Immune Globulin Intravenous (human)] 5% Liquid Preparation: Market Withdrawal - Risk of Thromboembolic Events

August 25, 2010 by RecallAware
Filed under: Medicine 

Customers asked to immediately quarantine the use of affected lots due to the potential for serious thromboembolic events.

Source:Full Article

Tags:

Comments

Readers of this site appreciate your comments

You must be logged in to post a comment.

References and links to other sites are provided as a courtesy. The recall and safety information provided here is based entirely on manufacturers' and regulatory agencies' press release or other public information. We make no other representations about the accuracy or timeliness of this information